Edgewise Therapeutics Inc. Common Stock vs Ferguson Enterprises Inc. Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.11 (market cap $4.02B), while Ferguson Enterprises Inc. Common Stock trades at $222 (market cap $43.13B). The key difference: Ferguson Enterprises Inc. Common Stock is far larger — about 10.7× Edgewise Therapeutics Inc. Common Stock's market cap, and Ferguson Enterprises Inc. Common Stock pays a 1.6% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Ferguson Enterprises Inc. Common Stock for 0 Days on average.
| EWTX | FERG | |
|---|---|---|
Market Cap | $4.02B | $43.13B |
Volume | 1,446,128 | 1,358,634 |
Sector | Health | Industrials |
52-Week High | $48.35 | $267.71 |
52-Week Low | $14.89 | $214.26 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.56B | $49.58B |
Dividend Yield | — | 1.6% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →Ferguson Enterprises, Inc. distributes plumbing, HVAC, waterworks, and related building products to professional contractors, builders, and facility managers across North America, operating through branches, showrooms, and digital commerce.
Read more on FERG →